Most Americans are down on the economy and the stock market, despite economic growth and the equity rally. Here’s a look at objective reality. Read More
John Persinos is the editorial director of Investing Daily, overseeing such publications as Personal Finance, Utility Forecaster, Profit Catalyst Alert, Rapier's Income Accelerator, Income Forecaster, and Marijuana Investing Daily, among others. John also writes the Mind Over Markets daily stock market recap, and he's the chief investment strategist of Marijuana Profit Alert.
John has decades of experience in the technology and political realms. He has worked as a staff editor at Inc. and Venture magazines, and written for Kiplinger's, Street Authority, Investing Answers, and TheStreet.com, to name a few. In a career that has spanned more than 40 years, John has been diligently and prolifically covering the news and its impact on investors.
John also has experience with the inner-workings of Capitol Hill, serving as a press secretary to U.S. Rep. Byron Dorgan (D-ND). John started his career as a daily newspaperman with The Orlando Sentinel.
John holds undergraduate and graduate degrees from Boston University. He also completed the Davenport Fellowship in Business and Economics Reporting at the University of Missouri (Columbia).
Analyst Articles
The U.S. economy is decelerating but that’s actually a good thing, because it relieves inflationary pressures. Read More
This week, Canada achieved a milestone in medicinal psychedelics as it granted authorization to a fledgling company to export these compounds. Read More
Here’s a look at key investment trends that have been occurring beneath the surface of everyday news coverage. Read More
No one likes to think about it, but how would you handle the financial fallout if your spouse suddenly died? Here’s a checklist of steps. Read More
The latest PCE data showed moderating inflation, boosting the odds of lower interest rates. Here are the equity sectors you should consider. Read More
Research into LSD, psilocybin, and other psychedelics is accelerating, as biotech firms race to develop new drugs based on these substances. Read More
Here’s why rigidly following the sell in May strategy could lead to missed opportunities. This month, for example, has been great for stocks. Read More
Waiting for the Fed’s first rate cut resembles the famous absurdist play in which an eagerly expected visitor never shows up. Read More
New research has found that psilocybin tends to inspire the belief that animals, plants and even inanimate objects have consciousness. Read More